Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

IDX/DGNS stock hub

IDX/DGNS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/DGNSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

360B

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/DGNS

In the news

Latest news · IDX/DGNS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.4P50 14.4P75 23.9

Trailing P/E107.7

P25 11.5P50 23.8P75 52.6

ROE1.7

P25 0.6P50 5.1P75 12.2

ROIC1.4

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/DGNS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

206

Groups with data

Currency

IDR

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	81
Employees Change	-15%
Employees Change Percent	-15.63
Enterprise value	IDR 430.5B
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	ID1000158702
Last refreshed	2026-05-10
Market cap	IDR 360B
Price	IDR 288
Price currency	IDR
Rev Per Employee	2,111,843,409.49x
Sector	Healthcare
Sic	8071
Symbol	idx/DGNS
Website	https://diagnos.co.id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.93%
EV Earnings	128.66x
EV/EBIT	65.85x
EV/EBITDA	25.78x
EV/FCF	75.99x
EV/Sales	2.52x
FCF yield	1.57%
P/B ratio	1.78x
P/E ratio	107.65x
P/S ratio	2.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.82%
EBITDA Margin	8.46%
FCF margin	3.31%
Gross margin	47.77%
Gross Profit	IDR 81.7B
Gross Profit Growth	19.02%
Gross Profit Growth Q	23.24%
Gross Profit Growth3 Y	0.75%
Gross Profit Growth5 Y	-7.9%
Net Income	IDR 3.3B
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Net Income Growth3 Y	61.21%
Net Income Growth5 Y	-46.01%
Pretax Margin	3.4%
Profit Margin	1.96%
Profit Per Employee	IDR 41.3M
Profitable Years	2
ROA	1.31
Roa5y	5.91
ROCE	2.28
ROE	1.69
Roe5y	8.8
ROIC	1.38
Roic5y	10.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	75.68%
Cagr3y	10.06%
Cagr5y	-15.46%
EPS Growth Quarters	2
EPS Growth Years	2
EPS Growth3 Y	73.83
EPS Growth5 Y	-47.74
FCF Growth5 Y	-21.65%
OCF Growth	-35.93%
OCF Growth3 Y	106.54%
OCF Growth5 Y	-19.44%
Revenue Growth	7.91x
Revenue Growth Q	11.93x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	-0.31x
Revenue Growth5 Y	-7.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.55
Assets	IDR 318.7B
Cash	IDR 7.6B
Current Assets	IDR 93.5B
Current Liabilities	IDR 32.3B
Debt	IDR 78.1B
Debt EBITDA	IDR 4.68
Debt Equity	IDR 0.39
Debt FCF	IDR 13.78
Equity	IDR 202.7B
Interest Coverage	8.43
Liabilities	IDR 116.1B
Long Term Assets	IDR 225.2B
Long Term Liabilities	IDR 83.7B
Net Cash	IDR -70.5B
Net Cash By Market Cap	IDR -19.59
Net Debt EBITDA	IDR 4.87
Net Debt Equity	IDR 0.35
Net Debt FCF	IDR 12.45
Tangible Book Value	IDR 201B
Tangible Book Value Per Share	IDR 161
WACC	6.26

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.89
Inventory Turnover	14.58
Net Working Capital	IDR 64.3B
Quick ratio	1.86
Working Capital	IDR 61.2B
Working Capital Turnover	IDR 2.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.06%
Dividend per share	IDR 0
Last Dividend	IDR 4.8

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	75.61%
200-day SMA	207.6
3Y total return	33.33%
50-day SMA	292.9
50-day SMA vs 200-day SMA	50over200
5Y total return	-56.82%
All Time High	1,485
All Time High Change	-80.61%
All Time High Date	2021-07-05
All Time Low	121
All Time Low Change	138.02%
All Time Low Date	2025-03-24
ATR	19.65
Beta	0.59
Beta1y	0.27
Beta2y	0.63
Ch YTD	56.52
High	300
High52	382
High52 Date	2026-02-25
High52ch	-24.61%
Low	272
Low52	136
Low52 Date	2025-10-10
Low52ch	111.77%
Ma50ch	-1.68%
Price vs 200-day SMA	38.71%
RSI	54.86
RSI Monthly	56.18
RSI Weekly	61.88
Sharpe ratio	1.34x
Sortino ratio	3.28
Total Return	-0.06%
Tr YTD	56.52
Tr1m	-1.37%
Tr1w	7.46%
Tr3m	-5.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR 6.5B
Operating Income Growth3 Y	35.15
Operating Income Growth5 Y	-41.16
Operating margin	3.82

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	287,174,700%
Net Borrowing	-3,692,557,473
Shares Out	1,250,000,000
Shares Qo Q	0.28%
Shares Yo Y	0.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR 5.7B
Average Volume	2,281,060x
Bv Per Share	162.1
CAPEX	IDR -6.7B
Ch1m	-1.37
Ch1w	7.46
Ch1y	75.61
Ch3m	-5.26
Ch3y	33.33
Ch5y	-57.01
Ch6m	98.62
Change	6.67%
Change From Open	5.88
Close	270
Days Gap	0.74
Depreciation Amortization	7,931,628,242
Dollar Volume	1,169,654,400
Earnings Date	2026-08-07
EBIT	IDR 6.5B
EBITDA	IDR 14.5B
EPS	IDR 2.68
F Score	7
FCF	IDR 5.7B
FCF EV Yield	1.32x
FCF Per Share	IDR 4.53
Financing CF	-4,480,569,473
Fiscal Year End	December
Founded	2,007
Graham Number	98.79128
Graham Upside	-65.7
Income Tax	IDR 2.5B
Investing CF	-7,141,008,047
Is Primary Listing	1
Last Earnings Date	2025-10-31
Last Report Date	2026-03-31
Lynch Fair Value	IDR 13.38
Lynch Upside	-95.36
Ma150	226.9
Ma150ch	26.91%
Ma20	279.1
Ma20ch	3.19%
Net CF	731,056,043
Next Earnings Date	2026-08-07
Open	272
P FCF Ratio	63.55
P OCF Ratio	29.14
Position In Range	57.14
Ppne	207,148,810,921
Price Date	2026-05-08
Price EBITDA	IDR 24.88
Ptbv Ratio	1.79
Relative Volume	1.86x
Revenue	171,059,316,169x
Tax By Revenue	1.44x
Tax Rate	42.46%
Tr6m	98.62%
Volume	4,061,300

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IDX/DGNS pay a dividend?

Capital-return profile for this ticker.

Performance

IDX/DGNS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDX/DGNS?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

IDX/DGNS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.9

Neutral momentum band

Price vs 200-day MA

+38.7%

50/200-day relationship not available

Beta (5Y)

0.59

Less volatile than the market

Sharpe ratio

1.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/DGNS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/DGNS stock rating?

idx/DGNS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/DGNS analysis?

The full report lives at /stocks/idx/DGNS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/DGNS?

The latest report frames idx/DGNS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/DGNS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.